Product NewsCeNeS strengthens the patent portfolio for its lead clinical programme M6G (morphine-6-glucuronide)
Product NewsMorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD® in Cancer Research
Product NewsDe nouvelles données montrent qu'Herceptin entraîne un bénéfice remarquable en termes de survie lors de cancer du sein HER2-positif au stade précoce
Product NewsEMEA, the European Medicines Agency, recommends that the EU Commission should grant TopoTarget European marketing authorisation for Savene™
Product NewsAstro Instrumentation, LLC and Immunicon Corporation Team Up to Provide Automated Breakthrough System for Cancer Detection
Product NewsMorphoSys' Antibodies by Design Establishes Antibody Series in Partnership with Japanese Kazusa DNA Research Institute
Product NewsFirst European Product Containing Delta Biotechnology’s Recombumin® Receives Marketing Approval from the EMEA
Product NewsEXONHIT DEPOSE UN BREVET SUR UN PANEL DE GENES POUR LE DIAGNOSTIC SANGUIN DE LA MALADIE D’ALZHEIMER
Product NewsBioProgress announces the OTC launch of sore throat treatment, Collunovar for Dexo France
Product NewsOxford Biomedica reports encouraging preclinical data with Retinostat® in Retinopathy and demonstrates the potential of Lentivector® in other ocular diseases
Product NewsUnmet Medical Needs, Positive Regulatory Frameworks and Increased Investments Support Continued Stem Cell Research
Product NewsEMEA Adopts Positive Opinion on First European Product Containing Delta Biotechnology’s Recombumin® (recombinant human albumin)
Product NewsTopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
